BRIEF-JW (Cayman) Therapeutics H1 Net Income RMB -267.3 Million

Reuters
Aug 27
BRIEF-JW (Cayman) <a href="https://laohu8.com/S/LENZ">Therapeutics</a> H1 Net Income RMB -267.3 Million

Aug 27 (Reuters) - JW (Cayman) Therapeutics Co Ltd 2126.HK:

  • H1 GROSS MARGIN OF SALES OF PRODUCTS 51.1%

  • H1 REVENUE RMB 106.3 MILLION

  • H1 NET INCOME RMB -267.3 MILLION

  • H1 GROSS PROFIT RMB 65.1 MILLION

Further company coverage: 2126.HK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10